ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,808Medicare Part D Prescriptions Filled, Including Refills

Rank: 53 out of 3593

$1.07M Total Retail Price of All Prescriptions

Rank: 114 out of 3593

729 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 729 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

21% of this provider’s 729 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 20,710 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 1,127 925 1 5
SIMVASTATIN 996 806 2 1
LISINOPRIL 982 815 3 2
AMLODIPINE BESYLATE 849 707 4 3
HYDROCODONE-ACETAMINOPHEN 741 497 S3 5 7
METFORMIN HCL 734 574 6 6
LEVOTHYROXINE SODIUM 609 496 7 4
MELOXICAM 550 458 8 29
GABAPENTIN 491 344 9 16
METOPROLOL TARTRATE 462 390 10 8
CARVEDILOL 459 395 11 23
RANITIDINE HCL 449 370 12 27
FUROSEMIDE 416 346 13 9
ZOLPIDEM TARTRATE 413 290 14 12
PRAVASTATIN SODIUM 410 321 15 13
GLIMEPIRIDE 389 311 16 44
IBUPROFEN 361 259 17 43
LOSARTAN POTASSIUM 359 286 18 14
PROAIR HFA 322 226 19 54
ALENDRONATE SODIUM 282 241 20 22
METOPROLOL SUCCINATE 275 226 21 19
HYDROCHLOROTHIAZIDE 266 205 22 10
SERTRALINE HCL 255 184 23 28
ENALAPRIL MALEATE 239 192 24 38
NEXIUM 239 187 24 36
FLUTICASONE PROPIONATE 236 184 26 32
TRAMADOL HCL 235 166 27 17
GLIPIZIDE 220 190 28 40
CLOPIDOGREL 219 183 29 30
JANUVIA 207 187 30 81
LOVASTATIN 201 145 31 20
MEGESTROL ACETATE 200 164 R 32 152
NIFEDIPINE ER 199 191 33 75
CITALOPRAM HBR 198 154 34 25
METOCLOPRAMIDE HCL 198 164 34 145
VENTOLIN HFA 193 141 36 80
ADVAIR DISKUS 192 140 37 47
CIPROFLOXACIN HCL 190 152 38 52
LISINOPRIL-HYDROCHLOROTHIAZIDE 187 114 39 26
AZITHROMYCIN 184 135 40 34
POTASSIUM CHLORIDE 181 149 41 24
NAPROXEN 175 134 42 68
CRESTOR 172 170 43 21
TAMSULOSIN HCL 169 150 44 33
DIOVAN HCT 160 136 45 76
MECLIZINE HCL 159 140 46 96
DIOVAN 158 158 47 46
LANTUS 157 147 48 57
PLAVIX 154 131 49 42
DONEPEZIL HCL 152 123 50 31
WARFARIN SODIUM 145 119 51 18
ATENOLOL 139 87 52 11
LOSARTAN-HYDROCHLOROTHIAZIDE 136 92 53 48
FAMOTIDINE 136 112 53 70
PAROXETINE HCL 128 76 55 62
FINASTERIDE 127 126 56 79
AMLODIPINE BESYLATE-BENAZEPRIL 127 108 56 65
NYSTATIN 116 84 58 167
FENOFIBRATE 114 76 59 39
MUPIROCIN 113 88 60 132
AMOXICILLIN 113 69 60 128
BUSPIRONE HCL 112 90 62 156
CLONIDINE HCL 108 85 63 41
OXYBUTYNIN CHLORIDE 108 88 63 104
ISOSORBIDE MONONITRATE ER 107 103 65 61
NYSTATIN-TRIAMCINOLONE 105 85 66 203
CYCLOBENZAPRINE HCL 105 51 R 66 72
EASY TOUCH 104 89 68 302
TRAZODONE HCL 103 81 69 53
BACLOFEN 103 83 69 109
KETOCONAZOLE 101 78 71 118
ALPRAZOLAM 100 64 72 37
CLOTRIMAZOLE-BETAMETHASONE 100 77 72 94
CLOBETASOL PROPIONATE 100 73 72 187
METHYLPREDNISOLONE 95 66 75 103
FLUOXETINE HCL 88 70 76 60
LOVAZA 87 68 77 106
OXYCODONE HCL-ACETAMINOPHEN 86 40 S2 78 82
AMITRIPTYLINE HCL 84 71 R 79 90
INSULIN SYRINGE 82 74 80 91
CARISOPRODOL 82 0 R 80 97
ATORVASTATIN CALCIUM 82 45 80 15
SPIRIVA 82 58 80 87
BENAZEPRIL HCL 79 60 84 69
ACTOS 79 72 84 133
SPIRONOLACTONE 74 62 86 86
MIRTAZAPINE 73 56 87 64
LIDODERM 72 69 88 78
DICYCLOMINE HCL 72 49 88 190
TRICOR 72 48 88 130
SINGULAIR 72 53 88 77
PANTOPRAZOLE SODIUM 72 56 88 45
AMOX TR-POTASSIUM CLAVULANATE 71 50 93 138
ACETAMINOPHEN-CODEINE 70 66 S3 94 153
OXYCODONE-ACETAMINOPHEN 69 46 S2 95 93
GLYBURIDE 69 58 R 95 55
NAMENDA 63 63 97 50
TRIAMTERENE-HYDROCHLOROTHIAZID 63 63 97 231
NASONEX 61 42 99 192
NOVOLIN 70-30 60 48 100 146
VOLTAREN 60 55 100 85
GEMFIBROZIL 60 55 100 88
DICLOFENAC SODIUM 60 24 100 74
ESCITALOPRAM OXALATE 60 43 100 71
NITROSTAT 59 55 105 224
NOVOLIN N 59 53 105 340
ALLOPURINOL 59 33 105 35
GLIPIZIDE XL 58 58 108 179
GENTAMICIN SULFATE 57 44 109 318
HYDROCORTISONE 56 47 110 273
TRIAMCINOLONE ACETONIDE 54 25 111 119
QUETIAPINE FUMARATE 54 42 111 89
GLYBURIDE-METFORMIN HCL 52 43 R 113 95
MONTELUKAST SODIUM 52 41 113 151
LACTULOSE 51 32 115 126
GLIPIZIDE ER 50 50 116 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 7, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.